Preferred Pain Center Chosen as the First Arizona Pain Management Center to Study Stem Cell Injections for Low Back Pain

Share Article

Preferred Pain Center in Phoenix and Scottsdale, AZ, chosen as the first and only pain management center in Arizona to begin studying low back pain patients with revolutionary Stem Cell research project. Patients with low back pain from facet disease may qualify for study enrollment.

News Image
The Stem Cell rich product is a non-steroidal substance with cell regenerative potential and it's regulated by the FDA - this is what we have been looking for in pain management!

Preferred Pain Center in Phoenix, Arizona, USA, has been selected as the only Arizona pain center to conduct a ground-breaking Stem Cell injection research study. The study is evaluating a stem cell rich injection substance for the treatment of low back pain due to facet arthritis.

The gold standard in the treatment of low back pain with facet disease has been steroid injections with numbing medication such as Lidocaine. While it works well with good to excellent results over 75% of the time, the injections do not alter the course of arthritis. In addition, steroid injections have limitations on how often they can be injected.

"The holy grail of arthritis has been to discover a cell regenerating substance which relieves pain and alters the course of the disease by regenerating the joint. While steroid injections do well with pain relief, we're excited about studying a Non-Steroidal, Anti-Inflammatory, Stem-Cell rich substance that has the potential for cartilage regeneration and pain relief. This is as cutting edge as it gets," said David Greene, MD, CEO of Preferred Pain Center.

The stem cell rich tissue injection is FDA regulated and has been injected over 3000 times successfully to date in the US for numerous applications, including wound healing, spine fusion, and scar prevention around the spinal cord. Preferred Pain Center will be the first to evaluate the stem cell injection product specifically for Interventional Pain Management.

The lead investigator for the study, Ajay Narwani, MD, is a Double Board Certified, Fellowship Trained Phoenix Pain Doctor. "The best interventional treatment we have right now for low back due to facet arthritis, apart from radiofrequency ablations, are steroid injections. I would love it if this study achieves more effective, lasting pain relief with the Stem Cell injections when compared to steroids. The Stem Cell rich product is a non-steroidal substance with cell regenerative potential and it's regulated by the FDA - this is what we have been looking for in pain management!"

The Stem-Cell rich tissue product is made from the amniotic fluid of live donors, and is not embryonic. It is non-steroidal and is processed and packaged at an FDA registered tissue bank that is ISO certified and AATB accredited and adheres to Current Good Tissue Practice Standards.

All patients will be followed for a minimum of six months and variables looked at will include pain reduction, work status, and narcotic medication reduction. The initial pilot study will include 50 patients with a larger follow up study to follow.

Preferred Pain Center is Phoenix and Scottsdale, AZ's most comprehensive and modern Arizona Pain Center. Treatment options at the Center include Medication Management, Interventional Pain Management, PT/Rehab, Phoenix Chiropractor, Acupuncture, Spinal Decompression Treatment, and Manipulation Under Anesthesia.

Study enrollment has begun, and prospective low back pain patients can apply at the Stem Cell Study web page or simply call Preferred Pain Center at (602) 507-6550 for more information. Enrollment is limited, so call today.

# # #

Share article on social media or email:

View article via:

Pdf Print

Contact Author

David Greene, MD, CEO
Visit website